Insulin Pump or CGM Denied by Insurance? Here's How to Appeal

Insulin pumps and continuous glucose monitors (CGMs) are among the most evidence-supported diabetes management technologies available. They improve glycemic control, reduce dangerous hypoglycemic episodes, lower HbA1c, and significantly reduce the long-term complication burden — including kidney disease, neuropathy, and retinopathy — for many patients. The American Diabetes Association (ADA) Standards of Medical Care in Diabetes and expanded 2023 CMS coverage determinations both strongly support these devices. Despite this clinical consensus, they are among the most frequently denied diabetes treatments. The good news: with the right documentation and appeal strategy, these denials are reversed regularly.

Why Insurers Deny Insulin Pumps and CGMs

"Not medically necessary" — the primary denial basis. Insurers apply clinical criteria that often lag behind current ADA guidelines. Specific denial grounds include HbA1c not meeting the plan's threshold (plans often require above 7.0% or 8.0%, despite ADA guidance supporting individualized targets and device use for patients at risk for hypoglycemia regardless of HbA1c level), inadequate documentation of hypoglycemic episodes or glycemic variability, and failure to document a trial of multiple daily injections (MDI) that did not achieve glycemic goals.

Type 2 diabetes exclusions. Some plans restrict insulin pump and CGM coverage to Type 1 diabetes patients (ICD-10: E10.x). This is increasingly inconsistent with clinical evidence showing that CGMs and pumps benefit many insulin-using Type 2 patients (E11.x), and with the 2023 CMS National Coverage Determination that expanded CGM coverage to all Medicare beneficiaries with diabetes who use insulin.

Device-specific formulary restrictions. Plans cover specific CGM brands (Dexcom, Libre) or specific pump models and deny newer automated insulin delivery (AID) systems or tubeless pumps as "not covered" or "investigational," even when the requested device is the most clinically appropriate option for the patient's specific management needs.

Step therapy violations. Plans require documentation that the patient tried and failed to achieve glycemic goals on an optimized MDI regimen before approving pump therapy. When this documentation is not explicit in the medical record, the claim is denied on step therapy grounds rather than clinical grounds.

Medicare DMEPOS requirements. For Medicare beneficiaries, insulin pumps are classified as durable medical equipment under HCPCS code E0784. CGMs are covered under HCPCS code A9276 (therapeutic CGM supply) as of the 2023 coverage expansion. Documentation requirements are specific and strict; missing any required element generates denial regardless of clinical appropriateness.

How to Appeal an Insulin Pump or CGM Denial

Step 1: Obtain the Denial and the Insurer's Coverage Criteria

Request your denial letter, EOB)" class="auto-link">Explanation of Benefits (EOB), and the insurer's clinical coverage policy for insulin pumps or CGMs. The coverage criteria document specifies exactly what the insurer required — HbA1c thresholds, frequency of hypoglycemia, MDI documentation requirements — and whether your documentation addressed each criterion. For Medicare Advantage denials, request the applicable Local Coverage Determination (LCD) from your MAC jurisdiction.

Step 2: Get Your Endocrinologist's Letter of Medical Necessity

Your endocrinologist's or treating physician's letter is the cornerstone of the appeal. It must include the ICD-10 diagnosis code (E10.649 for Type 1 diabetes with hypoglycemia; E11.649 for Type 2 diabetes with hypoglycemia), current and historical HbA1c values with dates, documentation of hypoglycemic episodes including any severe events requiring assistance (ER visits, glucagon administration, loss of consciousness), evidence of hypoglycemia unawareness if present — which is itself a strong standalone indication for CGM and pump therapy — and a citation to the ADA Standards of Medical Care in Diabetes for the current year, which supports CGM use for all adults with Type 1 diabetes and insulin-using adults with Type 2.

Step 3: Document Hypoglycemia and Glycemic Variability

Gather blood glucose logbook data or meter download reports covering at least two to three weeks, showing glycemic variability, time-below-range events, and hypoglycemic episodes. For CGM appeals, trial CGM data showing coefficient of variation and time-below-range is highly compelling if available. Document any severe hypoglycemic events: emergency room visits, 911 calls, glucagon kit use, or episodes requiring assistance from another person. Hypoglycemia unawareness — where the patient cannot perceive falling blood glucose — is one of the strongest clinical indications for both CGM and pump therapy and should be specifically attested to by the treating physician.

Step 4: Document MDI Failure for Insulin Pump Appeals

For insulin pump appeals specifically, compile prescription records, pharmacy dispensing records, and clinical notes that show the patient was on an optimized MDI regimen — including both basal and bolus insulin analogs — for an adequate trial period, and that this regimen did not achieve the clinical goals specified in the insurer's coverage criteria. The documentation must show what the MDI regimen was, for how long it was trialed, what the glycemic outcomes were, and why pump therapy is expected to address the specific failure mode of MDI for this patient.

Step 5: Request a Peer-to-Peer Review and File the Internal Appeal

Ask your endocrinologist to request a peer-to-peer review with the insurer's medical director within five days of the denial. A clinical conversation about specific HbA1c history, documented hypoglycemia events, and patient-specific risk factors resolves many device denials without a full written appeal. If peer-to-peer does not resolve the denial, file the formal internal appeal addressing every criterion in the insurer's coverage policy, citing the ADA Standards of Medical Care and — for Medicare patients — the 2023 CMS National Coverage Determination for CGMs (available at cms.gov). For state-regulated plans in California, Illinois, or New York, cite the applicable state diabetes device coverage mandate.

Step 6: Escalate to External Independent Review: Complete Guide" class="auto-link">External Review and State Regulators

If the internal appeal fails, file for independent external review. For Medicaid denials, request a state fair hearing. External reviewers with endocrinology expertise evaluate the clinical merits against ADA guidelines and CMS coverage determinations rather than the insurer's internal criteria. File simultaneously with your state insurance commissioner for state-regulated plan denials that violate state diabetes device mandates, or with the Department of Labor EBSA at 1-866-444-3272 for ERISA employer plans.

What to Include in Your Appeal

• Endocrinologist's letter of medical necessity with ICD-10 code (E10.x or E11.x), current and historical HbA1c, hypoglycemia documentation, and ADA Standards of Medical Care citation supporting the requested device for this patient's specific clinical profile
• Blood glucose meter download or CGM data showing glycemic variability, time-below-range, and hypoglycemic event frequency over at least two to three weeks
• Records of severe hypoglycemic episodes — ER visit records, glucagon prescription history, or physician documentation of episodes requiring third-party assistance
• MDI prescription and pharmacy records for pump appeals, documenting the specific regimen trialed, duration, and glycemic outcomes showing inadequate control

Fight Back With ClaimBack

Insulin pump and CGM denials are among the most winnable insurance appeals when the clinical record is complete. The ADA Standards of Medical Care, the 2023 CMS CGM coverage expansion, and state diabetes device mandates all support these technologies. ClaimBack generates a professional, diabetes-specific appeal letter in 3 minutes, tailored to your device type, denial reason, and ICD-10 diagnosis code.

Start your free claim analysis →

Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal